Cancer patients may respond differently to the same treatment. This disparity in response has prompted researchers to develop new methods to predict which drugs would be most effective in treating individual tumours. 

The current issue of TrialScribe includes articles featuring the newly released Requirements for Performing Vital Signs Measurements Policy, news on the Fall 2013 Clinical Research Exchange sessions, and a case study on effective ways to ensure safety and accuracy when taking vital signs measurements. You can read TrialScribe by clicking here.

(note: link only accessible internal to UHN) 

The November issue of NRx (formerly known as Net Results Express) is now available. In this month’s issue you can read about the grand opening of the Krembil Discovery Tower, a new treatment for HIV infection and predicting the response to a therapy for depression.